About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Houston | 22,399 Studies Near You

Clinical TrialsHouston

Clinical Trials in Houston

Discover 22,399 clinical trials near Houston, Texas. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 2141-2160 of 22,399 trials

CompletedStudy of TS-022 in Adult Patients With Atopic Dermatitis With Pruritus (POC)The purpose and (primary) objectives of this study are to evaluate the efficacy, safety, and tolerability of TS-022 in adults with atopic dermatitis who have moderate to very…NCT00914186·La Jolla, California and 14 others Not yet recruitingZavegepant Intranasal Spray for the Acute Treatment of Episodic Cluster HeadacheThe purpose of this study is to assess headache response rate for minimal pain at 30 minutes following zavegepant administration and to assess additional effectiveness and…NCT07714369·Houston, Texas TerminatedBronchitis and Emphysema Advice and Training to Reduce HospitalizationEXECUTIVE SUMMARY: Purpose: To evaluate the efficacy and cost-effectiveness of a novel intervention incorporating self-management education, an action plan, and case-management…NCT00395083·Phoenix, Arizona and 21 others

Find Trials by Condition in Houston

Breast Cancerin Houston Lung Cancerin Houston Prostate Cancerin Houston Colorectal Cancerin Houston Melanomain Houston Leukemiain Houston Lymphomain Houston Pancreatic Cancerin Houston Ovarian Cancerin Houston Brain Cancerin Houston Diabetes

Data from ClinicalTrials.govTerms

CompletedStudy Evaluating the Safety, Efficacy and Tolerability of BIO89-100 in Subjects With Biopsy-confirmed Nonalcoholic Steatohepatitis (NASH)This is a randomized, double-blind, placebo-controlled study that will evaluate the safety, efficacy, tolerability of BIO89-100 in patients with biopsy-confirmed fibrosis stages…NCT04929483·Birmingham, Alabama and 88 others

CompletedPatiromer for the Management of Hyperkalemia in Subjects Receiving RAASi Medications for the Treatment of Heart Failure (DIAMOND)The purpose of this study is to assess the effects of patiromer compared with placebo on serum K+ in HF patients.NCT03888066·Alexander City, Alabama and 414 others

CompletedSafety, Tolerability, Pharmacokinetic and Microbiological Investigation of GSK3882347 in Female Participants With Urinary Tract InfectionsThis phase 1b study is a double-blind, double-dummy, nitrofurantoin-controlled study designed to evaluate microbiological response at the test of cure (ToC) visit along with…NCT05138822·Anniston, Alabama and 14 others

CompletedMultivirus-specific T Cells for the Treatment of Virus Infections After Stem Cell TransplantPatients enrolled on this study will have received a stem cell transplant. After a transplant, while the immune system grows back the patient is at risk for infection.NCT02108522·Houston, Texas and 1 other

CompletedComplement Factor H Haplotypes and Smoking in Age-related Macular DegenerationRisk factors for Age-related Macular Degeneration (AMD) involves genetic variations in the alternative pathway of complement inhibitor factor H.NCT01115231·Charleston, South Carolina and 1 other

Active not recruitingFPI-2265 (225Ac-PSMA-I&T) for Patients With PSMA-Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC)This is an open-label, randomized, multicenter study of FPI-2265 (225Ac-PSMA-I\&T).NCT06402331·Duarte, California and 17 others

CompletedOpen-Label Safety Study of ADS-5102 in PD Patients With LIDThis is a 105-week open-label study to evaluate the safety and tolerability of ADS-5102 oral capsules, an extended release formulation of amantadine, in Parkinson's Disease (PD)…NCT02202551·Birmingham, Alabama and 86 others

CompletedA Study of the Safety and Efficacy of Ustekinumab (CNTO 1275) in Patients With Moderate to Severe PsoriasisThe primary objective of this study is to evaluate the efficacy and safety of ustekinumab (CNTO 1275) in the treatment of patients with moderate to severe plaque psoriasis.NCT00307437·Birmingham, Alabama and 61 others

CompletedSafety of Inhaled Insulin With Type 1 and Type 2 DiabetesPulmonary Safety in Diabetics with T/INCT00308737·Phoenix, Arizona and 175 others

TerminatedSafety and Efficacy of 50 mg NYX-783 QD vs. Placebo in PTSDA Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of 50 mg NYX-783 Once Daily Compared to Placebo in Participants with Post-Traumatic Stress…NCT05181995·Tuscaloosa, Alabama and 36 others

CompletedAntibiotic Therapy With or Without G-CSF in Treating Children With Neutropenia and Fever Caused by ChemotherapyRATIONALE: Antibiotics may decrease the side effects of neutropenia and fever caused by chemotherapy.NCT00003739·Birmingham, Alabama and 234 others

CompletedLosartan to Reverse Sickle NephropathySickle cell disease causes kidney damage with increasing age, leading to chronic kidney disease and renal failure in nearly one third of patients with sickle cell disease.NCT01479439·Chicago, Illinois and 8 others

CompletedA Trial of the Fatty Acid Amide Hydrolase Inhibitor Palmitoylethanolamide in Bipolar DepressionThe purpose of this study is to o evaluate the antidepressant efficacy of the PEA in Bipolar Depression and the association between antidepressant response with endogenous…NCT06229977·Houston, Texas

RecruitingDynamic Contrast-Enhanced Magnetic Resonance Imaging in Diagnosing Osteoradionecrosis in Patients With Head and Neck Cancer That Is Primary, Has Come Back, or Has Spread to Other Places in the BodyThis trial studies how well dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) works in diagnosing osteoradionecrosis in patients with head and neck cancer that is…NCT03145077·Houston, Texas

CompletedA Phase I Trial of ZIO-101 in Hematologic CancersThis study uses a new investigational (not yet approved by the FDA for widespread use) drug called ZIO-101, an organic arsenical.NCT00592046·Houston, Texas

Active not recruitingTesting the Addition of Nivolumab to Standard Treatment for Patients With Metastatic or Unresectable Colorectal Cancer That Have a BRAF MutationThis phase II trial tests whether adding nivolumab to the usual treatment (encorafenib and cetuximab) works better than the usual treatment alone to shrink tumors in patients with…NCT05308446·Goodyear, Arizona and 285 others

CompletedStudy of Encorafenib + Cetuximab Plus or Minus Binimetinib vs. Irinotecan/Cetuximab or Infusional 5-Fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab With a Safety Lead-in of Encorafenib + Binimetinib + Cetuximab in Patients With BRAF V600E-mutant Metastatic Colorectal CancerThis is a multicenter, randomized, open-label, 3-arm Phase 3 study to evaluate encorafenib + cetuximab plus or minus binimetinib versus Investigator's choice of either…NCT02928224·Phoenix, Arizona and 417 others

PreviousPage 108 of 1120Next

in Houston

Heart Diseasein Houston